Crossmark

Evaluation of efficacy and safety of low-intensity pulsed ultrasound in patients with concurrent erectile dysfunction and chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized controlled study

Crossref DOI link: https://doi.org/10.1186/s12894-024-01630-5

Published Online: 2024-10-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Zhongyi

Li, Dongjie

Zu, Xiongbing

Xiang, Boyu

Wang, Guilin

Tang, Zhengyan
License Information

Text and Data Mining valid from 2024-10-22

Version of Record valid from 2024-10-22
More Information

Article History

Received: 28 May 2024

Accepted: 17 October 2024

First Online: 22 October 2024

Declarations

:

: This single‑center, prospective randomized controlled study was approved by the institutional review board of the ethics committee of Xiangya Hospital of Central South University (approval number: No. 202204087 on April 22, 2022) and was performed according to the principles of the Declaration of Helsinki. The study protocol was prospectively registered at a publicly accessible clinical registration site that is recognized by the International Committee of Medical Journal Editors (Chinese Clinical Trial Registry, approval number: ChiCTR2200063038 on August 29, 2022). Written informed consent was obtained from all patients at our hospital who were enrolled between August 2022 to November 2022.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below